Profil de l'entreprise pour Cyclo Therapeutics, Inc. - Warrant Action
Cyclo Therapeutics, Inc. engages in the development of cyclodextrin-based biopharmaceuticals for the treatment of disease. Its product pipeline include Trappsol Cyclo, which treats Neimann-Pick Type C disease and Alzheimer's disease. The company was founded by Charles E. Rick Strattan on August 9, 1990 and is headquartered in Gainesville, FL.
Analyse IA de Cyclo Therapeutics, Inc. - Warrant
Cliquez sur l’une des analyses ci-dessous pour obtenir des informations instantanées de l’IA via finAgent
Dernières analyses d’IA sur Cyclo Therapeutics, Inc. - Warrant
Aucun fil IA disponible pour cette entreprise pour le moment.